Tianming Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tianming Wang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Cai Feng
Department of Radiology, Hunan Engineering Research Center for Intelligent Medical Imaging of Central South University, Furong Laboratory, Molecular Imaging Research Center of Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China
2 shared publicationsHao Zhou
Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China
2 shared publications- Peng Lei
Department of Radiology, Hunan Engineering Research Center for Intelligent Medical Imaging of Central South University, Furong Laboratory, Molecular Imaging Research Center of Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China
2 shared publications - Weihua Liao
Department of Radiology, Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Xiangyu Chen
Department of Radiology, The Second Xiangya Hospital, Central South University, Changsha, China
2 shared publications Xianting Sun
Department of Radiology, Hunan Engineering Research Center for Intelligent Medical Imaging of Central South University, Furong Laboratory, Molecular Imaging Research Center of Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China
2 shared publications
Latest Publications
- 8 January 2026
- Published by Elsevier in Biomaterials
- Vol. 330, 123993
Harnessing the HMnO2 nanoparticles as the DNA injury amplifier to improve the OXA-based trans-artery infusion chemotherapy
- 8 January 2026
- Published by Elsevier in Biomaterials
- Vol. 330, 123993
Harnessing the HMnO2 nanoparticles as the DNA injury amplifier to improve the OXA-based trans-artery infusion chemotherapy
- 16 May 2023
- Published by Elsevier in Biomaterials
- Vol. 299, 122164
Beyond antioxidation: Harnessing the CeO2 nanoparticles as a renoprotective contrast agent for in vivo spectral CT angiography
- 16 May 2023
- Published by Elsevier in Biomaterials
- Vol. 299, 122164
Beyond antioxidation: Harnessing the CeO2 nanoparticles as a renoprotective contrast agent for in vivo spectral CT angiography
- Open Access
- 18 October 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (10) , 1924
A Promising and Challenging Approach: Radiologists’ Perspective on Deep Learning and Artificial Intelligence for Fighting COVID-19
Chest X-rays (CXR) and computed tomography (CT) are the main medical imaging modalities used against the increased worldwide spread of the 2019 coronavirus disease (COVID-19) epidemic. Machine learning (ML) and artificial intelligence (AI) technology, based on medical imaging fully extracting and utilizing the hidden information in massive medical imaging data, have been used in COVID-19 research of disease diagnosis and classification, treatment decision-making, efficacy evaluation, and prognosis prediction. This review article describes the extensive research of medical image-based ML and AI methods in preventing and controlling COVID-19, and summarizes their characteristics, differences, and significance in terms of application direction, image collection, and algorithm improvement, from the perspective of radiologists. The limitations and challenges faced by these systems and technologies, such as generalization and robustness, are discussed to indicate future research directions.
- 18 October 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (10) , 1924
Open AccessA Promising and Challenging Approach: Radiologists’ Perspective on Deep Learning and Artificial Intelligence for Fighting COVID-19
Chest X-rays (CXR) and computed tomography (CT) are the main medical imaging modalities used against the increased worldwide spread of the 2019 coronavirus disease (COVID-19) epidemic. Machine learning (ML) and artificial intelligence (AI) technology, based on medical imaging fully extracting and utilizing the hidden information in massive medical imaging data, have been used in COVID-19 research of disease diagnosis and classification, treatment decision-making, efficacy evaluation, and prognosis prediction. This review article describes the extensive research of medical image-based ML and AI methods in preventing and controlling COVID-19, and summarizes their characteristics, differences, and significance in terms of application direction, image collection, and algorithm improvement, from the perspective of radiologists. The limitations and challenges faced by these systems and technologies, such as generalization and robustness, are discussed to indicate future research directions.